Novan Therapeutics, the biotechnology company raises $50 M

What does Novan Therapeutics do?

Novan Therapeutics, is a clinical stage drug development company which is focused on developing deliverable nitric oxide. The company develops products which tap anti-bacterial properties of nitric oxide by encapsulating the compound in nano particles that delivers the therapeutic agents to desires location of the body.

This privately held, clinical stage biotech company focuses on advancing innovation in dermatology through nitric oxide therapies. Its core technologies solve the previous delivery issues with nitric oxide by storing the gaseous species stably on macromolecules which result in a diverse pipeline of timed release of new chemical entities which release nitric oxide.

How much Novan Therapeutics was funded?

The clinical stage biotechnology company has raised $50 M in the latest round of venture funding on March 30^th, 2015 from Malin Corporation.

Previous funding

• $2M in Venture funding on Jul 1^st, 2009
• $4M in Venture funding on Jan 18^th, 2011
• $6M in  Series C funding on Oct 14^th, 2011
• $11M in Venture funding on February 28^th, 2013
• $3.5M in Debt Financing on Mar 10^th, 2014
• $10.3M  in Venture funding on Aug 29^th, 2014

What is next for Novan Therapeutics?

The latest round of funding will help Novan biotherapeutics efforts to create first class, impactful, nitric oxide based healthcare solutions in numerous large market indications.

More about Novan Therapeutics

Novan  Therapeutics is a private, clinical stage biotech organization which is accelerating possibly best in therapies with the use of drug able nitric oxide, it being one of the most researched molecules in human being physiology. It shows a wide anti-microbial activity and promotes vasodilatation, regulates inflammation, stimulates the repair of tissues and eradicates cancer cells. The Novan Therapeutics is focusing initially on skin diseases which are physically and emotionally debilitating. Its patented technology, Nitricil has overcome the delivery issues associated previously with nitric oxide by storing it as a solid which can be changed into purposeful medical analysis.